| Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer N Rajana, A Mounika, PS Chary, V Bhavana, A Urati, D Khatri, SB Singh, ... Journal of Controlled Release 352, 1024-1047, 2022 | 33 | 2022 |
| Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations A Nathani, L Sun, I Khan, M Aare, A Bagde, Y Li, M Singh Pharmaceutics 16 (1), 83, 2024 | 5 | 2024 |
| Cannabidiol and beta-caryophyllene combination attenuates diabetic neuropathy by inhibiting NLRP3 inflammasome/NFκB through the AMPK/sirT3/nrf2 axis I Khan, S Kaur, AK Rishi, B Boire, M Aare, M Singh Biomedicines 12 (7), 1442, 2024 | 1 | 2024 |
| Enhanced oral bioavailability and in vitro evaluation of cannabidiol camel milk-derived exosome formulation in resistant MDA-MB-231 and MDA-MB-468 breast cancer cells M Aare, A Bagde, A Nathani, AK Rishi, M Singh International Journal of Pharmaceutics 663, 124375, 2024 | | 2024 |
| Unlocking the Potential of Camel Milk-Derived Exosomes as Novel Delivery Systems: Enhanced Bioavailability of ARV-825 PROTAC for Cancer Therapy A Nathani, M Aare, L Sun, A Bagde, Y Li, A Rishi, M Singh Pharmaceutics 16 (8), 1070, 2024 | | 2024 |
| TEMPORARY REMOVAL: Enhanced oral bioavailability and in vitro evaluation of cannabidiol camel milk-derived exosome formulation in resistant MDA-MB-231 and MDA-MB-468 breast … M Aare, A Bagde, A Nathani, AK Rishi, M Singh International Journal of Pharmaceutics, 2024 | | 2024 |
| Synergistic anticancer activity of cannabinoids and beta caryophyllene in xenograft mouse model of triple negative breast cancer M Aare, I Khan, A Nathani, B Boirie, A Bagde, M Singh Cancer Research 84 (6_Supplement), 4566-4566, 2024 | | 2024 |
| BRD4 protein degradation for p53 mutant diffuse intrinsic pontine glioma (DIPG) via various delivery approaches for ARV-825 by using camel milk exosomes A Nathani, M Aare, L Sun, Y Li, M Singh Cancer Research 84 (6_Supplement), 7578-7578, 2024 | | 2024 |
